Clinical Trial Update: Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports on eliminating adjuvant chemotherapy for selected stage II and III nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: COMPLETED